“…On the contrary, antidiabetic drugs of the sulfonylurea family, known to stimulate the pancreatic secretion of INS, appear to have a negative impact on BC growth, also increasing BC risk [ 148 , 149 , 150 ]. Furthermore, the overexpression of insulin and/or the insulin growth factor 1 gene are associated with a decrease in the length of the life of women with BC, while their suppression increases life span and decreases tumorigenesis [ 28 , 103 , 142 , 143 , 145 , 146 , 147 , 151 , 152 , 153 , 154 , 155 , 156 , 157 ]. Hyperinsulinemia has also been considered an important factor in a wide array of human malignancies, while insulin inhibition has been proposed to decrease their growth [ 158 , 159 ].…”